Alamar Biosciences Inc.
ALMR | NASDAQ
$29.10
-$1.50 (-4.90%)
Nov 2, 2026, 1:16 PM ET · Market open
Market Data
Market Cap $2.02B
Enterprise Value $1.92B
Beta -6.18
Average Volume 490K
Shares Outstanding (Diluted) 58.67M
Shares Change YoY N/A
Institutional Ownership 35.54%
Exchange NASDAQ
ISIN US0109111056
Price Performance
Price Change 1M -15.3%
Price Change 3M 7.5%
Price Change 6M 22.5%
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -12.2%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR 84.9%
Valuation
PE Ratio -57.74
Forward PE N/A
PEG Ratio -0.58
Forward PEG 1.27
PS Ratio 38.29
Forward PS 12.80
PB Ratio 6.79
P/FCF Ratio -59.13
P/Adj. FCF Ratio -59.13
P/OCF Ratio -56.67
EV/Sales 34.70
EV/EBIT -57.10
EV/EBITDA -59.15
EV/FCF -53.60
Earnings Yield -1.7%
FCF Yield -1.7%
Adj. FCF Yield -1.7%
Financial Health
Net Cash $237.83M
Total Debt $51.41M
Cash & Short-Term Investments $250.05M
Total Assets $390.98M
Current Ratio 11.85
Quick Ratio 10.23
Debt / Equity Ratio 0.16
Debt / EBITDA -1.58
Debt / FCF -1.43
OCF / Debt -0.62
Interest Coverage -57.89
Altman Z-Score 16.37
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 58.0%
Operating Profit Margin -46.7%
EBITDA Margin -56.6%
Net Profit Margin -62.3%
FCF Margin -64.8%
Adj. FCF Margin -64.8%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -8.8%
Return on Equity 428.6%
Return on Invested Capital -7.1%
Return on Capital Employed -7.1%
Return on Tangible Assets -8.9%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 2
EPS Growth Next 3Y 37.7%
Revenue Growth Next 3Y 75.1%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.20
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $30.22M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $33.50
Price Target Upside 9.5%
Cash Flow
Operating Cash Flow $-31.67M
Free Cash Flow $-35.91M
Adj. Free Cash Flow $-35.91M
FCF Per Share -$0.61
OCF Per Share -$0.54
OCF/S Ratio -57.1%
Income Statement
Revenue $55.46M
Gross Profit $32.18M
Operating Income $-25.88M
EBITDA $-32.54M
Net Income $-34.52M
EPS (Diluted) -$0.53
Revenue / Employee $249.83K
Profit / Employee $-155.51K
Employees 222
Add to Watchlist
Select watchlists to add or remove ALMR